Your browser doesn't support javascript.
loading
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trial.
Krilaviciute, Agne; Albers, Peter; Lakes, Jale; Radtke, Jan Philipp; Herkommer, Kathleen; Gschwend, Jürgen; Peters, Inga; Kuczyk, Markus; Koerber, Stefan A; Debus, Jürgen; Kristiansen, Glen; Schimmöller, Lars; Antoch, Gerald; Makowski, Marcus; Wacker, Frank; Schlemmer, Heinz; Benner, Axel; Giesel, Frederik; Siener, Roswitha; Arsov, Christian; Hadaschik, Boris; Becker, Nikolaus; Kaaks, Rudolf.
Afiliación
  • Krilaviciute A; Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Albers P; Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lakes J; Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
  • Radtke JP; Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
  • Herkommer K; Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
  • Gschwend J; Department of Urology, Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Munchen, Germany.
  • Peters I; Department of Urology, Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Munchen, Germany.
  • Kuczyk M; Department of Urology, Medical University Hannover, Hannover, Germany.
  • Koerber SA; Department of Urology, Krankenhaus Nordwest, Frankfurt am Main, Germany.
  • Debus J; Department of Urology, Medical University Hannover, Hannover, Germany.
  • Kristiansen G; Department of Radiation Oncology, Heidelberg University Hospital, Ruprecht Karls University, Heidelberg, Germany.
  • Schimmöller L; Department of Radiation Oncology, Heidelberg University Hospital, Ruprecht Karls University, Heidelberg, Germany.
  • Antoch G; Institute of Pathology, University Hospital Bonn, Bonn, Germany.
  • Makowski M; Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
  • Wacker F; Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
  • Schlemmer H; Institute of Diagnostic and Interventional Radiology, Technical University Munich, München, Germany.
  • Benner A; Institute of Diagnostic and Interventional Radiology, Medical University Hannover, Hannover, Germany.
  • Giesel F; Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Siener R; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Arsov C; Department of Nuclear Medicine, Medical Faculty, Duesseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
  • Hadaschik B; Department of Radiation Oncology, Heidelberg University Hospital, Ruprecht Karls University, Heidelberg, Germany.
  • Becker N; Department of Urology, University Hospital Bonn, Bonn, Germany.
  • Kaaks R; Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Int J Cancer ; 152(5): 854-864, 2023 03 01.
Article en En | MEDLINE | ID: mdl-36121664
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania